[
  {
    "slug": "farmmi-subsidiary-completes-fda-registration-for-us-food-facility",
    "title": "Farmmi subsidiary completes FDA registration for US food facility",
    "description": null,
    "fullText": null,
    "readingTime": 0,
    "keywords": [],
    "qualityScore": 0,
    "link": "https://www.investing.com/news/company-news/farmmi-subsidiary-completes-fda-registration-for-us-food-facility-93CH-4446853",
    "thumbnail_url": "https://i-invdn-com.investing.com/news/world_news_2_108x81.jpg",
    "created_at": "2026-01-14T12:24:56.840Z",
    "topic": "finance"
  },
  {
    "slug": "agios-begins-us-launch-of-thalassemia-drug-following-fda-approval",
    "title": "Agios begins U.S. launch of thalassemia drug following FDA approval",
    "description": null,
    "fullText": null,
    "readingTime": 0,
    "keywords": [],
    "qualityScore": 0,
    "link": "https://www.investing.com/news/company-news/agios-begins-us-launch-of-thalassemia-drug-following-fda-approval-93CH-4441580",
    "thumbnail_url": "https://i-invdn-com.investing.com/news/world_news_2_108x81.jpg",
    "created_at": "2026-01-12T12:26:13.638Z",
    "topic": "finance"
  },
  {
    "slug": "nationwide-cheese-recall-carries-risk-of-deathheres-what-to-know",
    "title": "Nationwide Cheese Recall Carries Risk Of Death—Here's What To Know",
    "description": "The FDA upgraded Ambriola Pecorino Romano to a Class I recall for Listeria. Check Boar's Head and other grated cheese dates through 2026 in 20 states.",
    "fullText": "The Ambriola Company recalled thousands of batches of Pecorino Romano cheese due to contamination with Listeria monocytogenes.\n\nThe recall has been bumped up to Class I status, meaning that consuming the affected product could result in serious adverse health consequences, or even death.\n\nThe recall pertains to numerous brands, including Boar's Head, which was distributed throughout 20 U.S. states.\n\nBack in November, a major producer recalled thousands of batches of its Pecorino Romano cheese due to the confirmed presence of Listeria monocytogenes. This week, the FDA bumped up the recall to Class I status, meaning consumption of the product has a high probability of causing \"serious adverse health consequences or death.\"\n\nAll of the products involved in the recall have expiration dates well into 2026, so it's worth checking your refrigerator now to make sure none of them are sitting on your shelf. The recall pertains to numerous brands of grated Pecorino that were distributed throughout 20 states, including Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Illinois, Indiana, Massachusetts, Maine, New Jersey, New York, Ohio, Oregon, Pennsylvania, Texas, Virginia, Washington, and Wisconsin.\n\nBoar's Head Grated Pecorino Romano sold in a 6-ounce cup with expiration dates of 3/4/2026 and 3/12/2026.\n\nLocatelli Pecorino Romano Grated sold in a 4-ounce cup with expiration dates of 5/3/2026, 5/10/2026, and 5/17/2026.\n\nLocatelli Pecorino Romano Grated sold in an 8-ounce cup with expiration dates of 4/6, 4/11, 4/12, 4/15, 4/17, 5/5, 5/6, 5/7, 5/10, 5/12, 5/14, and 5/17/2026.\n\nMember's Mark Pecorino Romano 1.5-pound bag with expiration dates of 3/25/206, 3/30/2026, and 4/5/2026.\n\nAdditionally, the following products were sold by the pound and are also included in the recall:\n\nAmbriola Grated Pecorino Romano with expiration dates of 2/28, 3/4, and 3/11/2026.\n\nBoar's Head Pecorino Romano Grated bag with expiration dates of 3/3 and 3/12/2026.\n\nLocatelli Grated Pecorino Roman with expiration dates of 3/4, 3/6, 3/11, and 3/13/2026.\n\nPinna Grated Pecorino Romano with the expiration date 3/11/2026.\n\nAccording to the original recall, Ambriola is working with the FDA to test both its products and facilities to determine the cause of the contamination. Customers who have the affected products should not consume them and should either dispose of them or return them to their place of purchase for a full refund.\n\nInsanely Easy Weeknight Dinners To Try This Week\n\n29 Insanely Delicious Vodka Cocktails",
    "readingTime": 2,
    "keywords": [
      "listeria monocytogenes",
      "class status",
      "romano cheese",
      "recall ambriola",
      "cheese due",
      "serious adverse",
      "adverse health",
      "health consequences",
      "numerous brands",
      "distributed throughout"
    ],
    "qualityScore": 1,
    "link": "https://www.yahoo.com/news/articles/nationwide-cheese-recall-carries-risk-171500726.html",
    "thumbnail_url": "https://s.yimg.com/ny/api/res/1.2/0mwH5D63i20eLMMNf.S3qA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU7Y2Y9d2VicA--/https://media.zenfs.com/en/delish_597/ba262008b9c300a96b451359adb2589a",
    "created_at": "2026-01-09T18:18:49.642Z",
    "topic": "news"
  },
  {
    "slug": "fda-identifies-deficiencies-in-aquestives-anaphylm-application",
    "title": "FDA identifies deficiencies in Aquestive’s Anaphylm application",
    "description": null,
    "fullText": null,
    "readingTime": 0,
    "keywords": [],
    "qualityScore": 0,
    "link": "https://www.investing.com/news/company-news/fda-identifies-deficiencies-in-aquestives-anaphylm-application-93CH-4439299",
    "thumbnail_url": "https://i-invdn-com.investing.com/news/world_news_2_108x81.jpg",
    "created_at": "2026-01-09T12:23:58.277Z",
    "topic": "finance"
  },
  {
    "slug": "viridians-thyroid-eye-disease-drug-receives-fda-priority-review",
    "title": "Viridian’s thyroid eye disease drug receives FDA priority review",
    "description": null,
    "fullText": null,
    "readingTime": 0,
    "keywords": [],
    "qualityScore": 0,
    "link": "https://www.investing.com/news/company-news/viridians-thyroid-eye-disease-drug-receives-fda-priority-review-93CH-4432107",
    "thumbnail_url": "https://i-invdn-com.investing.com/news/world_news_2_108x81.jpg",
    "created_at": "2026-01-06T12:24:19.854Z",
    "topic": "finance"
  },
  {
    "slug": "fda-grants-breakthrough-therapy-status-to-alkermes-narcolepsy-drug",
    "title": "FDA grants breakthrough therapy status to Alkermes’ narcolepsy drug",
    "description": null,
    "fullText": null,
    "readingTime": 0,
    "keywords": [],
    "qualityScore": 0,
    "link": "https://www.investing.com/news/company-news/fda-grants-breakthrough-therapy-status-to-alkermes-narcolepsy-drug-93CH-4432106",
    "thumbnail_url": "https://i-invdn-com.investing.com/news/world_news_2_108x81.jpg",
    "created_at": "2026-01-06T12:24:19.853Z",
    "topic": "finance"
  },
  {
    "slug": "scinopharm-taiwan-receives-fda-approval-for-ms-treatment",
    "title": "ScinoPharm Taiwan receives FDA approval for MS treatment",
    "description": null,
    "fullText": null,
    "readingTime": 0,
    "keywords": [],
    "qualityScore": 0,
    "link": "https://www.investing.com/news/company-news/scinopharm-taiwan-receives-fda-approval-for-ms-treatment-93CH-4428767",
    "thumbnail_url": "https://i-invdn-com.investing.com/news/world_news_2_108x81.jpg",
    "created_at": "2026-01-05T06:25:09.246Z",
    "topic": "finance"
  },
  {
    "slug": "corcept-therapeutics-stock-price-target-cut-by-canaccord-on-fda-setback",
    "title": "Corcept Therapeutics stock price target cut by Canaccord on FDA setback",
    "description": null,
    "fullText": null,
    "readingTime": 0,
    "keywords": [],
    "qualityScore": 0,
    "link": "https://www.investing.com/news/analyst-ratings/corcept-therapeutics-stock-price-target-cut-by-canaccord-on-fda-setback-93CH-4427594",
    "thumbnail_url": "https://i-invdn-com.investing.com/news/news_headline_rolled_108x81.jpg",
    "created_at": "2026-01-02T12:22:19.278Z",
    "topic": "finance"
  },
  {
    "slug": "guggenheim-reiterates-buy-rating-on-axsome-stock-amid-fda-priority-review",
    "title": "Guggenheim reiterates Buy rating on Axsome stock amid FDA priority review",
    "description": null,
    "fullText": null,
    "readingTime": 0,
    "keywords": [],
    "qualityScore": 0,
    "link": "https://www.investing.com/news/analyst-ratings/guggenheim-reiterates-buy-rating-on-axsome-stock-amid-fda-priority-review-93CH-4427600",
    "thumbnail_url": "https://i-invdn-com.investing.com/news/news_pile_108x81.jpg",
    "created_at": "2026-01-02T12:22:19.188Z",
    "topic": "finance"
  },
  {
    "slug": "fda-grants-priority-review-for-axsomes-alzheimers-agitation-drug",
    "title": "FDA grants priority review for Axsome’s Alzheimer’s agitation drug",
    "description": null,
    "fullText": null,
    "readingTime": 0,
    "keywords": [],
    "qualityScore": 0,
    "link": "https://www.investing.com/news/company-news/fda-grants-priority-review-for-axsomes-alzheimers-agitation-drug-93CH-4426423",
    "thumbnail_url": "https://i-invdn-com.investing.com/news/world_news_2_108x81.jpg",
    "created_at": "2025-12-31T12:22:36.959Z",
    "topic": "finance"
  },
  {
    "slug": "fda-supports-axsomes-nda-submission-for-narcolepsy-drug-axs12",
    "title": "FDA supports Axsome’s NDA submission for narcolepsy drug AXS-12",
    "description": null,
    "fullText": null,
    "readingTime": 0,
    "keywords": [],
    "qualityScore": 0,
    "link": "https://www.investing.com/news/company-news/fda-supports-axsomes-nda-submission-for-narcolepsy-drug-axs12-93CH-4426413",
    "thumbnail_url": "https://i-invdn-com.investing.com/news/world_news_2_108x81.jpg",
    "created_at": "2025-12-31T12:22:36.944Z",
    "topic": "finance"
  },
  {
    "slug": "us-fda-approves-vanda-pharmaceuticals-motion-sickness-drug",
    "title": "US FDA approves Vanda Pharmaceuticals’ motion sickness drug",
    "description": null,
    "fullText": null,
    "readingTime": 0,
    "keywords": [],
    "qualityScore": 0,
    "link": "https://www.investing.com/news/stock-market-news/us-fda-approves-vanda-pharmaceuticals-motion-sickness-drug-4426090",
    "thumbnail_url": "https://i-invdn-com.investing.com/trkd-images/LYNXMPELBT0X7_L.jpg",
    "created_at": "2025-12-31T00:57:57.262Z",
    "topic": "finance"
  }
]